Work / Animation / Idiopathic Pulmonary Fibrosis and the Effects of Treatment
About 50,000 people in the United States are diagnosed with IPF each year. After diagnosis, the estimated survival is only 3 years. Patients with IPF deteriorate to the extent that most die of respiratory failure; essentially their lungs can’t get enough oxygen into their blood.
The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
The 6.5-minute animation shows in great detail how the lungs work to get oxygen into the blood, how the lung tissue is repaired when damage occurs, and how this repair process goes awry in IPF.
Idiopathic Pulmonary Fibrosis and the Effects of Treatment
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer…
In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation to illustrate the mechanism of…
XVIVO was approached by the NIH (National Institutes of Health) to help raise awareness of extracellular RNA (exRNA). After working…
Brian Greene, Professor Mathematics & Physics, Columbia University
Through their creative prowess and technical mastery, XVIVO is defining and redefining the very frontier of scientific animation. As science and medicine explore increasingly remote realms, their work provides a vital link allowing researchers and the general public to grasp visually an astonishing landscape of new possibilities.